经营现金流“失血”、贸易应收款项攀升，国医科技港股IPO胜算几何？

Core Viewpoint - Anhui Zhongji Guoyi Medical Technology Co., Ltd. (referred to as "Guoyi Technology") has submitted its listing application, with Haitong International as its sole sponsor. The company is a third-party SPD solution provider and is the largest in China by market share, which is 29.2% as of 2024 revenue projections [1]. Group 1: Company Overview - Guoyi Technology was established in 2016 and has deployed its SPD solutions in 116 hospitals across 13 provinces in China by September 30, 2025 [1]. - The company reported revenues of approximately RMB 248 million, RMB 378 million, and RMB 306 million for the fiscal years 2023, 2024, and the first three quarters of 2025, respectively. The corresponding profits were RMB 12.31 million, RMB 57.58 million, and RMB 43.20 million [1]. Group 2: Cash Flow and Financial Performance - The company has experienced negative cash flow from operating activities, with net cash flows of RMB -24.82 million, RMB -53.31 million, and RMB -46.95 million for the respective periods [2]. - Guoyi Technology's cash flow from operating activities is primarily affected by its investment-driven business model, requiring significant upfront expenditures before achieving full revenue generation [2]. - The company anticipates continued negative cash flow from operating activities as it expands its SPD solution portfolio and invests in regional smart cloud warehouses and R&D activities [3]. Group 3: Accounts Receivable and Credit Risk - Trade receivables and notes receivable have been increasing, with amounts of approximately RMB 114 million, RMB 188 million, and RMB 219 million at the end of the respective reporting periods [3][4]. - The turnover days for trade receivables and notes receivable have increased significantly, recorded at 137 days, 145 days, and 180 days for the respective periods [3]. - The company has implemented measures to manage credit risk and improve collection efficiency, including regular assessments of receivables and taking legal action when necessary [4].